Babayeva S, Zilber Y, Torban E. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes. Am J Physiol Renal Physiol 300: F549-F560, 2011. First published June 9, 2010; doi:10.1152/ajprenal.00566.2009.-Glomerular podocytes are highly polarized cells characterized by dynamic actinbased foot processes (FPs). Neighboring FPs form specialized junctions, slit diaphragms (SDs), which prevent passage of proteins into the ultrafiltrate. The SD protein complex is linked to cytoskeletal actin filaments and mutations in SD proteins lead to a dramatic change in cell morphology; proteinuria is accompanied by FP retraction and loss of SD structure. Thus, organization of the podocyte cytoskeleton is tightly linked to filtration barrier function. In a variety of cell systems, cytoskeleton arrangement is regulated by the planar cell polarity (PCP) pathway. PCP signals lead to the appearance of highly organized cellular structures that support directional cell movement and oriented cell division. Derangement of the PCP pathway causes neural tube defects and cystic kidney disease in mice. Here, we establish that the PCP pathway regulates the cytoskeleton of podocytes. We identify expression of core PCP proteins in mouse kidney sections and of PCP transcripts in murine and human cultured podocytes. The pathway is functional since Wnt5a causes redistribution of PCP proteins Dishevelled and Daam1. We also show that Wnt5a treatment changes podocyte morphology, alters nephrin distribution, increases the number of stress fibers, and increases cell motility. In reciprocal experiments, siRNA depletion of the core PCP gene Vangl2 reduced the number of cell projections and decreased stress fibers and cell motility. Finally, we demonstrate direct interactions between Vangl2 and the SD protein, MAGI-2. This suggests that the PCP pathway may be directly linked to organization of the SD as well as to regulation of podocyte cytoskeleton. Our observations indicate that PCP signaling may play an important role both in podocyte development and FP cytoskeleton dynamics. polarized cells; podocyte cytoskeleton PODOCYTES ARE HIGHLY POLARIZED glomerular epithelial cells characterized by small actin-based foot processes (FP). The FPs of neighboring podocytes form specialized cell-cell contacts or "slit diaphragms" (SDs), which serve as a filtration barrier to protein and as a signaling nexus to relay information inside the cell (20, 40) . In early renal development, podocyte progenitor cells look like "normal" polygonal epithelial cells with distinct apico-basolateral polarity and typical tight junctions. As development proceeds, podocyte tight junctions descend toward the basolateral aspect of the cell and transform into SD bridges that contain podocyte-specific SD proteins, such as nephrin (41) . Some features of tight junctions are preserved, however, since SDs still express classical tight junction proteins such as ZO-1 (24) , MAGI-2 (31) , and proteins of the PAR polarity complex [Par6, Par3, and atypical protein kinase C (aPKC)] (11, 16, 19, 21) . Transformation of tight junction into SD coincides with initiation of FP growth; FPs become anchored to the glomerular basement membrane and develop long internal, contractile actin-myosin strands arranged in parallel (6) . Although the mature podocytes project into the urinary space, they make contact with each other at the SD interconnections and interdigitate their actin-based FPs in a strict alternating alignment along the axis of the glomerular capillary.
Podocyte function is directly related to its unique architecture. Mutation of SD components or targeted podocyte injury by drugs leads to proteinuria in association with changes in FP morphology, described as "smearing" or "effacement" (5) . In Finnish-type congenital nephrotic syndrome, caused by inherited mutations of nephrin, podocytes lack SDs and FPs are completely absent (25, 53) . Mutations in the podocyte proteins CD2AP and ␣-actinin-4, which directly interact with the actin cytoskeleton, lead to focal segmented glomeruloscelosis (FSGS) (54) . The anti-proteinuric effect of cyclosporin A was recently linked, in part, to stabilization of the actin cytoskeleton (9) . The FP cytoskeleton is highly dynamic. FP smearing can occur within a few min of exposure to a toxic agent and FP reassembly can be initiated immediately after subsequent perfusion of heparin (46) . Although FP structure can be rapidly altered by remodeling of the actin cytoskeleton, little is known about the molecular mechanisms involved.
The alternating interdigitation of podocyte FPs along the glomerular capillary is precisely organized in the direction of flow, reflecting a secondary axis of polarity perpendicular to the apico-basolateral direction. In many tissues, this form of planar cell polarity (PCP) is controlled by the PCP pathway; PCP signals induce cellular asymmetry that is perpetuated from cell to cell within the plane via cell-cell contacts (47) . PCP was originally discovered in fruitflies (12, 30) , where a number of core PCP genes including Frizzled, Van Gogh, Dishevelled, and Fat were identified by analysis of spontaneous mutations (10, 13, 22, 28, 49, 55, 61, 62) . PCP signaling results in asymmetric redistribution of core PCP proteins. This, in turn, brings about redistribution of actin-based cytoskeletal filaments and the appearance of oriented cellular protrusions (48) . In vertebrates, the PCP pathway is known as a noncanonical Wnt signaling pathway since it is activated by Wnt5a or Wnt11 but does not involve beta-catenin (60) . In mammals, PCP was found to regulate formation of actin-based lamellipodia in neuroepithelial cells, enabling the cells to migrate directionally during neural tube closure. Mutations of core murine PCP genes (including Vangl2, Dishevelled1,2,3) cause an embryonically lethal neural tube defect, craniorachiscisis (4, 8, 15, 26, 36, 50, 58, 59 ). The precise molecular cascade downstream from the core PCP proteins is not entirely clear, but it appears to involve small GTPases of the RhoA family and/or Jun kinase (27, 64) and disheveled associated activator of morphogenesis (Daam1) (14) . Daam1 is a formin-homology domain protein that binds actin and nucleates filament polymerization (33) .
Here, we report that the core PCP genes/proteins are expressed in podocytes and that PCP signaling affects podocyte shape and motility. We show that the PCP pathway regulates the intracellular distribution of PCP proteins Dvl2 and Daam1 and of filamentous actin in cultured podocytes. We show that the PCP pathway regulates distribution of nephrin and demonstrate direct interactions between Vangl2 and the SD protein MAGI-2. Based on these observations, we propose that the PCP pathway is an important regulator of the actin cytoskeleton in podocytes and contributes to morphogenesis of FPs. We speculate that disruption of the PCP signaling network could disturb podocyte biology and might affect their recovery after glomerular injury.
MATERIALS AND METHODS
Podocyte cultures and transfections. Immortalized temperaturesensitive murine podocytes (passages 8 -18) (7) were obtained from Dr. Takano and human podocytes AB8/13 (passages 6 -16) (43) were obtained from Dr. Goodyer (both McGill Univ., Canada). Both cell lines were propagated for 4 -5 days at 33°C in complete medium: RPMI-1640 supplemented with 10% FBS and 1% penicillin and streptomycin solutions (all from Wisent), 100 g/ml of Normocin (InvivoGen), and 10 U/ml of recombinant mouse ␥-interferon (Invitrogen). To permit differentiation, the cells were cultured at 37°C for 14 days in the same medium without ␥-interferon. Medium was changed every 48 h. For transfections, 5 ϫ 10 5 human or mouse podocytes were seeded into six-well plates, grown to 80% confluence at 33°C, and transfected with 1 g of DNA plasmids using Lipofectamine-2000 as indicated by the manufacturer (Invitrogen) to achieve 25-35% transfection efficiency.
L-cells stably expressing Wnt5a protein and control parental L cells [American Type Culture Collection (ATCC) no. CRL-2814 and CRL-2648, respectively] were grown as recommended by ATCC. Fresh conditioned medium containing 2-10% FBS was collected, filtered, and used within 24 h to treat podocytes. Human or mouse podocytes were grown in six-well plates either on coverslips (for immunofluorescent studies) or in plastic culture vessels (for protein assessment by Western immunoblotting) in complete medium as above. The podocyte medium was removed and substituted with L-CM or Wnt5a-CM, supplemented with 10 U/ml of ␥-interferon (for podocytes grown at 33°C) or without ␥-interferon (for differentiated podocytes). Podocytes were treated for 3-6 h and subsequently processed for immunofluorescent studies or immunoblotting.
Rat glomerular epithelial cells (rGEC4) stably expressing nephrin and podocin (gift from Dr. Takano) or COS7 cells were transiently transfected with GFP-Vangl2 or myc-Vangl2 (51) and/or full-length rat nephrin expression constructs (from Dr. Takano).
Detection of PCP genes. Cultured mouse and human podocytes, rGEC4, mouse embryonic day 13.5 (E13.5) tissues, rat fetal E20 and adult glomeruli (prepared by differential sieving as described in Ref. 42) were used to isolate mRNA by the TRIzol method (Sigma). Moloney murine leukemia virus (MMLV) reverse transcriptase (Invitrogen) was used to prepare cDNA pools, which were used for PCR amplifications with Taq Polymerase (Invitrogen). We detected PCP transcripts with the following primers: hVangl2-F 5=-cttcctgaaggtgcctcttg-3=; hVangl2-R 5=-gtgaggtcatcatgggaga-3=; hPrickl1-F 5=-aaaagcctctttcagccaca-3=; hPrickle1-R 5=-gtgcagcatggaagagttca-3=; hDaam1-F 5=-accctgactccacacctttg-3=; hDaam11-R 5=-caggcacagaggaaggaaag-3=; hDvl2-F 5=-ccgtcatgtgcttgctctta-3=; hDvl2-R 5=-tggaggaggaggtcacattc-3=; mVangl1-F 5=-cacaggcaaggggaaagaacaag-3=; mVangl1-R 5=-cacatccgctctttgcttgcg-3=; mVangl2-F 5=-ctaagagccgggatgggagtc-3=; mVangl2-R 5=-ggacggacttgggcaggttg-3=; mDvl2-F 5=-ccatgagtctcggacagaact-3=; mDvl2-R 5=-gtcctctccatgcgtggcggc-3=; mPrickle1-F 5=-gaggatgggcagaagcagccg-3=; mPrickle1-R 5=-cagatctagctcttgcagcc-3=; mScribble1-F 5=-gattctgcagagaccacggg-3=; mScribble1-R 5=-ctgctgcagcttgcgagcttcc-3=; mNephrin-F 5=-ctgactgggctgaagccttc-3=; mNeprhin-R 5=-gtacttcatcatagaggggtcc-3=. Mouse primers were designed to detect both mouse and rat sequences (except for rat Prickle1). Animal handling and animal tissue collection were done according to the rules and with the approval of the Animal Care Committee of the McGill University (AUP protocol no. 5423).
Vangl2 knockdown. Three different 21-bp siRNA target sequences for murine Vangl2 mRNA (NM_033509) were designed and cloned into pRNATin-H1.2/Hygro (GenScript) to produce Vangl2 shRNA constructs. The following sequences were used: tatctcagagaaattcaagcc, ttcttcaggccaagaggcacc, and tctgtggatcgcacgaccttg. pRNATin-H1.2/Hygro plasmid encodes a GFP reporter expressed under an independent promoter to facilitate cell visualization and establishing of the stable clones. Mouse podocytes grown at 33°C were transfected with 1 g of a mix of three shVangl2s or an empty vector used as a control and selected in 300 g/ml of hygromycin (BioShop) for 2 wk. Twelve individual hygromycin-resistant shVangl2 and six control clones were expanded at 33°C. mRNA was isolated by the TRIzol method (Invitrogen) and 1 g of each RNA was converted into cDNAs with MMLV reverse transcriptase (Invitrogen). Since Vangl2 protein is undetectable in podocytes, quantitative PCRs were carried out on the AB Applied Biosystems 7300 Real Time PCR System using QuantiTect SYBR Green PCR Kit (Qiagen) with the following specific Vangl2 primers: mVangl2-F 5=-agagccgggatgggagtcgtg-3=; mVangl2-R 5=-gagatactgtgctcagaagtc-3=. Vangl2 transcript levels were normalized for HRPT transcript amplified with mHRPT-F 5=-ggactgattatggacaggactg-3=; mHRPT-R 5=-tccagcaggtcagcaaagaac-3=. PCR reactions were performed with the 1/10 of each RT template (corresponding to 100 ng of mRNA) in a total volume 25 l in 96-well plates (AB Applied Biosystem). The following conditions were used: 95°C for 15 min, followed by 40 cycles of 94°C for 15 s, 60°C for 30 s, and 72°C for 30 s. For each clone (12 shVangl2 clones and 6 controls), we prepared mRNAs in duplicate and performed RT-qPCR in duplicate. We confirmed reduction of Vangl2 expression by additional RT-qPCR reactions (done in triplicate) for the clones with the Vangl2 depletion below 50%. Two individual control and three shVangl2 clones were initially used for the experiments; results are presented for one control and two shVangl2 clones (clones 8 and 12).
Immunofluorescence. E11 and E16.5 mouse embryos from timedpregnancy CD-1 females (Charles River) were cryopreserved, sectioned, and immunostained with polyclonal rabbit anti-Vangl2 antibody as previously described (52) . Confocal images were acquired on an Olympus FluoView microscope (Olympus).
Mouse or human proliferating podocytes (5 ϫ 10 5 ) were grown for 4 -5 days on coverslips at 33°C, fixed in 4% paraformaldehyde for 15 min, and permeabilized with 0.5% Triton X-100 in PBS. Cells were blocked in 10% normal goat serum (Jacksons Laboratory) and 0.1% Triton in PBS. ␣-Tubulin was immunodetected with mouse anti-␣-tubulin antibody (Sigma), Daam1 with anti-Daam1 (gift from Dr. Dunn), and nephrin with anti-nephrin (Dr. Takano) antibodies. The complexes were identified with donkey Alexa Fluor-546 anti-mouse or Alexa-488 anti-rabbit secondary antibodies, respectively (Molecular Probes). For stress fiber staining, fixed cells were blocked in 3% BSA (BioShop) in PBS and stained with Alexa Flour-568-conjugated Phalloidin (Molecular Probes). Nuclei were stained with DAPI (Invitrogen) and the slides were mounted in Prolong Gold Antifade (Molecular Probes). Cellular projections and stress fibers were counted (minimum 50 cells per clone per experiment) in three independent experiments for both human and mouse podocytes. Only stress fibers transversing the entire cell were counted. Z-projections of nuclear, tubulin, and actin staining were captured with an AxioObserver-100 microscope (Zeiss). Cos7 and rGEC4 cells were immunostained with polyclonal anti-nephrin antibody and monoclonal antimyc (9E10, Sigma) antibodies.
Podocytes transfected with Cherry-Dvl2 (a gift from Dr. Gros, McGill Univ.) were fixed 48 h posttransfection and stained with DAPI. The exogenous Dvl2 protein in unstimulated, transfected cells was previously reported to appear as "puncta" and to localize to the cytoplasmic vesicles of different sizes depending on the amount of the transfected cDNA (45) . In podocytes transfected with 1 g of CherryDvl2 cDNA, we observed two major arbitrary subdivided populations of medium size and large size Dvl2-positive vesicles. Subcellular distribution of Cherry-Dvl2 was analyzed in 300 cells X3 in two independent experiments for both mouse and human podocytes. For statistical analyses, cells with a vesicular localization of Dvl2 were pooled.
Immunoblotting. To detect Dvl2 phosphorylation, human podocytes were treated with L-CM or Wnt5a-CM as described above. Treated cells were washed with cold PBS and lysed at 4°C in PLC buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 0.5% Triton X-100, 1.5 mM MgCl 2, 1 mM EGTA, 2 mM Na2 vanadate, 10 mM Na2 pyrophosphate, 25 mM NaF, 1 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail (Bioshop). The lysates were resolved on SDS-PAGE (10%) and immunodetected with rabbit polyclonal anti-human Dvl2 antibody (H-75, Santa Cruz Biotechnology) followed by horseradish peroxidase-conjugated anti-rabbit IgG antibody (Jacksons Laboratory) and detected by the ECL method (West Pico ECL kit, Thermo Scientific).
Human podocytes grown at 33 or 37°C were lyzed in PLC buffer; 50 g of protein per lane for each sample were resolved on 8% SDS-PAGE and immunodetected with anti-nephrin or ani-Daam1 polyclonal antibodies. The loading was controlled for tubulin and immunodetected with anti-␤-tubulin antibody (Sigma). Immunoblotting for nephrin or Daam1 was repeated three times. Intensities of the protein expression detected in Western immunoblotting experiments were measured using Alpha Innotech AlphaImager system and AlphaEase FC32-bit software (ThermoFisher).
Wound-healing assay. Human and mouse podocytes were grown at 33°C to confluence in complete medium. A wound was scratched on the plate surface with a 10-l pipette tip and cells were photographed (0-h time point). The complete medium was replaced by ␥-interferonsupplemented L-CM or Wnt5a-CM and cells were incubated for 24 h at 33°C. Images were acquired using a AxiObservor-100 microscope (Zeiss). Twelve pictures per time point per plate were used to count cells migrating into equivalent wound areas within 24 h. The experiment was repeated twice in triplicate for each clone. Similar assays were performed with confluent shVangl2 monolayers (control, clones 8 and 12) incubated at 33°C in complete medium with ␥-interferon. The cells that had migrated into the wound within 10 h were counted as above. The experiment was repeated twice in triplicate.
Coimmunoprecipitation and GST-pull down assays. Coimmunoprecepitations and GST-pull down assays were performed as described previously (51) . Briefly, Vangl2-myc or GFP-Vangl2 and /or MAGI-2-Flag (gift from Dr. Tsuchida, Univ. of Tokushima, Japan) were transiently expressed in HEK293 cells or HEK293 cells stably expressing rat nephrin (from Dr. Takano) and lysed in PLC buffer. 1/20 Of each sample was reserved as an input fraction. The lysates (1 mg of protein per sample) were incubated overnight with anti-nephrin or anti-FLAG (Sigma) antibodies and Agarose A beads (Santa Cruz Biotechnology). The protein-antibody complexes were washed in PLC (4ϫ), resolved on 8% PAGE-SDS, and immunoblotted with antibodies indicated in Fig. 6 . The cytoplasmic domain of rat nephrin aminoacids 1100 -1253 cloned into pGEX-5X-2 (32) was purified from BL21 Escherichia coli on Sepharose 4B beads (Amersham Biosciences); GST-pull downs were carried out as described (51) .
Yeast two-hybrid assay. MatchMaker yeast two-hybrid system (Clonthech) was used to test for direct interactions between cytoplasmic domains of Vangl2 (239 -521 aa) and nephrin (1100 -1253 aa). Mouse Vangl2 cloned into pGBKT7 "bait" and mouse Dvl2-5= cloned into pGADT7 "prey" as well as empty pGBKT7 (encoding galactosidase-4-DNA-binding domain and myc-tag) and an empty pGADT7 (encoding GAL-4-transactivation domain and HA-tag) constructs were described previously (51) . A cDNA fragment encompassing cytoplasmic domain of the rat nephrin was generated by PCR using full-length rat nephrin expression vector (provided by Dr. Takano). Flanking EcoRI-HindIII sites were incorporated into the amplification primers and the resultant PCR product was cloned into pGADT7 plasmid. Sequence integrity and protein expression of all plasmids were confirmed by direct sequencing and Western blotting with anti-myc (Sigma) and anti-HA (Covance) antibodies to detect bait-and prey-based fusion proteins, respectively, as described in Torban et al. (51) . The interaction assays were carried out as previously described in Torban et al. (51) .
Statistical analysis. The Student's t-test was used to calculate statistical significance. Mean and standard deviations are shown in all graphs.
RESULTS

Expression of PCP genes in podocytes.
To characterize renal expression of Vangl2, we studied embryos at various developmental stages. At early stages (E11.5), we detected Vangl2 protein in the mesonephric duct and mesonephric tubules (Fig. 1A) . In midgestation (E16.5), high levels of Vangl2 protein were found in collecting ducts and developing tubular structures, including comma-and S-shaped bodies (Fig. 1, B and C) . In the commashaped body, we identified Vangl2 protein at points of cell-cell contact; its distribution appeared to be asymmetrically localized within the longitudinal plane of tubules, predominantly decorating one side of the basolateral surface (Fig. 1C, long arrows, the longitudinal plane is designated by a dashed arrow). Vangl2 protein was identified in glomeruli (Fig. 1, D-G) , where it was restricted to the basolateral aspects of podocytes in developing glomeruli at early and late capillary loop stages (Fig. 1, E and G, respectively) . In adult mouse or rat kidneys, Vangl2 protein expression was below the limit of detection. Podocytes are highly differentiated cells characterized by complex cytoskeletal arrangements and dynamic cytoskeletal regulation. Thus, our observation that podocytes express Vangl2, a "core" PCP protein, prompted us to determine whether the other known PCP pathway components are present in podocytes. Transcripts for core PCP genes Vangl1, Vangl2, and Dvl2 were detected in fetal and adult rat glomerular preparations (Fig. 1H) . To delineate the lineage of cells expressing PCP transcripts in glomeruli, we performed RT-PCR with RNA prepared from SV40 T-antigen-immortalized mouse (7) and human AB8/13 (43) podocytes grown at 33 and/or 37°C. We identified transcripts for Vangl1, Vangl2, Dvl1,2,3, Prickle1, Scribble, and Daam1 in both species (Fig. 1H ) and rGEC4. We confirmed differentiation of murine and human podocytes at 37°C by tracking expression of endogenous nephrin (Fig. 1H, m-pod 37 lane) .
Activation of the PCP signaling cascade in podocytes in vitro leads to actin rearrangement associated with Daam1 translocation and nephrin redistribution.
To activate PCP signaling in human AB8/13 and mouse podocytes, we used conditioned media produced by L cells stably expressing Wnt5a protein (Wnt5a-CM) or control parental L cells (L-CM); the same method has been used by others to activate PCP signaling in various systems (1, 37) . In mouse NIH3T3 fibroblasts, Wnt5a has been reported to increase formation of actin-based stress fibers and cause a redistribution of Daam1 along stress fibers (44) . We first confirmed these effects of Wnt5a-conditioned medium on NIH3T3 cells (data not shown) before testing it on podocytes.
In L-CM-treated proliferating human and mouse podocytes, filamentous actin was mostly compartmentalized in cortical areas ( Fig. 2A, short arrow) ; we also observed a few thin, short stress fibers at the cell center ( Fig. 2A, L-CM panels) . Proliferating human podocytes treated with Wnt5a-CM exhibited a more robust increase in the number of stress fibers per cell, compared with the cells exposed to L-CM (17.9 Ϯ 4.6 vs. 7.2 Ϯ 2.6, respectively; Fig. 2, A and B) . Although slightly less pronounced, the effect of Wnt5a on mouse podocyte stress fibers was similar (Fig. 2B) .
In both human and mouse podocytes, we detected a significant effect of Wnt5a on the distribution of Daam1, from a diffuse pattern in control L-CM-treated cells to the presence of large Daam1 aggregates localized along stress fibers in Wnt5a-stimulated cells (Fig. 2, Wnt5a-CM panel, long arrows) . This was particularly pronounced in differentiated human podocytes at 37°C (Fig. 2A) . Proliferating podocytes had higher Daam1 levels compared with the differentiated cells (Fig.  2D) ; however, treatment with Wnt5a-CM did not affect Daam1 protein levels (Fig. 2D) .
Stimulation of differentiated podocytes with Wnt5a-CM for 6 h caused redistribution of nephrin from cell projections (visualized by staining with phalloidin and indicated by the intermittent line) to internal cell compartments (Fig. 2C) without affecting the overall level of endogenous nephrin (Fig. 2E) .
PCP pathway acts through dishevelled in cultured podocytes. Activation of PCP pathway signaling leads to phosphorylation and translocation of Dvl2 from a cytoplasmic vesicular localization to the plasma membrane (1, 3, 39, 45, 58) . To test for the same phenomena in podocytes, we transfected a murine Dvl2-Cherry expression vector into human and mouse podocytes. In transfected human podocytes treated with control L-CM, 56.1 Ϯ 3.8% of the cells expressed Dvl2-Cherry within vesicular structures (puncta), visible as large and mostly medium-size Dvl2 protein aggregates [ Fig. 3A (medium size vesicles are shown) and 3D]; 43.9 Ϯ 3.8% of the cells displayed a homogenous Dvl2 localization at the plasma membrane (Fig. 3, B and D) . Wnt5a-CM treatment caused a significant shift in Dvl2 distribution (31.5 Ϯ 6.4% vesicular vs. 68.5 Ϯ 6.4% at the plasma membrane; Fig. 3D ). In mouse podocytes, the effect of Wnt5a-CM was even more pronounced: only 18.7 Ϯ 3.7% vesicular and 81.3 Ϯ 2.7% plasma membrane vs. 51.4 Ϯ 3.8% vesicular and 48.6 Ϯ 3.8% plasma membrane in control L-CM-treated cells (Fig. 3D) . Treatment of human podocytes for 4 h with Wnt5a-CM medium resulted in a significant increase in phosphorylation of endogenous Dvl2 protein compared with the Dvl2 phosphorylation level in cells treated with control L-CM: 53.3 Ϯ 1.3 vs. 35.7 Ϯ 1.4% of total Dvl2 protein, respectively ( Fig. 3C and Supplementary Fig. 1 ; the online version of this article contains supplemental data). We used anti-human polyclonal Dvl2 antibody (Santa Cruz Biotechnology); this antibody recognizes both unphosphorylated (higher relative mobility) and phosphorylated (lower relative mobility) species (Fig. 3C) .
Vangl2 depletion in podocytes results in morphologic changes, actin rearrangements, and nephrin redistribution.
The effects of PCP activation on stress fiber formation and Dvl2 redistribution strongly suggest a functional PCP pathway in podo- cytes. To corroborate these findings, we analyzed the consequences of PCP knockdown (siRNA interference) in stable podocyte transfectants with depleted Vangl2 mRNA. Two shRNA clones with depletion of Vangl2 mRNA to 30% (clone 8) and 40% (clone 12) of control level are shown (Supplementary Fig. 2) .
Staining with phalloidin revealed that Vangl2 depletion resulted in a substantial reduction in the number of stress fibers in proliferating mouse podocytes. On average, 20 Ϯ 5 stress fibers were found in control cells and more than 90% of cells displayed Ͼ12 stress fibers/cell (Fig. 4C) . In contrast, an average of eight stress fibers per cell were found in podocytes with depleted Vangl2 (clone 8: 8 Ϯ 3; clone 12: 8 Ϯ 3) and 90% of these cells exhibited Ͻ12 stress fibers per cell (Fig.  4C) . shVangl2 podocytes were often bigger than control clones, but appeared rounder and had significantly fewer cellular projections. On average, control podocytes had 7 Ϯ 1.2 cellular projections, whereas shVangl2 cells had an average of 4 projections/cell (clone 8 ϭ 4 Ϯ 0.9; clone 12 ϭ 4 Ϯ 0.7; Fig.  4B ). Differentiated mouse podocytes with depleted expression of Vangl2 were even more rounded and generally lacked cell projections ( Fig. 4D ; contours of the cells are designated by white intermittent lines), while the control cells sprouted extensive cell projections. Nephrin distribution differed markedly between shVangl2 and control cells: control cells expressed nephrin in cell projections (Fig. 4D, long arrows) or had a filamentous nephrin appearance (short arrow), whereas cells with depleted Vangl2 had a cytoplasmic, nonfilamentous distribution (Fig. 4D) .
PCP signaling affects directional podocyte movement. The PCP pathway is known to control directional movement in neuronal cells; in the early embryo, disruption of PCP signaling reduces convergent extension cell movements (56) . To investigate whether PCP activation (Wnt5a treatment) affects podocyte motility, we performed in vitro wound-healing assays with human and mouse podocytes (Fig. 5A) (Fig. 5B) .
Vangl2 interacts with the SD protein MAGI-2. PCP signals are propagated along the epithelial sheet via cell-cell contacts which in podocytes are constituted by SD bridges. This implies that PCP proteins may be linked to proteins of the SD complex. Since Vangl2 has a PDZ domain-binding motif at its COOH terminus, we analyzed whether it binds to the PDZ domain-containing SD protein MAGI-2 (which is known to interact directly with nephrin) (18, 31) . Indeed, we detected interactions between Vangl2 and MAGI2 by coimmunoprecipitation assays (Fig. 6A, top) . We used coimmunoprecipiation assays to confirm interactions between MA-GI-2 and nephrin (Fig. 6A, bottom) . To explore whether Vangl2 is linked to nephrin, we carried out GST-pull down assays with a cytoplasmic portion of rat nephrin tagged with GST. Our results demonstrate that Vangl2 is part of a ternary complex that also includes nephrin and MAGI-2 (Fig. 6B) . Vangl2 was pulled-down with nephrin in the absence of exogenous MAGI-2 (Fig. 6B, lane 3) ; however, we could not detect direct interactions between the COOHterminal part of Vangl2 and nephrin cytoplasmic domain as tested by a yeast two-hybrid interaction assay (Supplementary Fig. 3 ).
Both Vangl2 and nephrin are colocalized in the same domains at the plasma membrane (designated with the intermittent white lines) in Cos7 or rGEC4 cells transfected with Vangl2 (GFP-or myc-tagged) and nephrin expression vectors (Fig. 6C ).
DISCUSSION
In a wide variety of organisms, the PCP pathway is crucial for cytoskeletal rearrangements that enable directional cell movement during embryogenesis and that orient specialized cell projections in some tissues (e.g., in the inner ear). During development of the renal glomerulus, podocytes precursors move into organized positions along the glomerular capillary and extend actin filament-based FPs that interdigitate along an axis corresponding to the direction of blood flow. These parallels led us to hypothesize that PCP signaling might play an important role in podocyte biology and that the various PCP molecules should, therefore, be expressed in podocytes. This prediction was confirmed in two (murine and human) podocyte cell lines and in freshly isolated glomeruli from fetal rat kidney. Additionally, we showed that Vangl2 protein (as a marker for the PCP pathway) was present in the developing glomerulus. In the mature glomerulus, however, Vangl2 protein was sharply downregulated. Taken together, these observations suggest a potential role for the PCP pathway during early nephrogenesis and in the primary organization of podocytes within glomeruli. To establish that the PCP pathway is functional in podocytes, we examined the effect of Wnt5A stimulation in vitro and observed a variety of characteristic PCP responses including recruitment of Dvl2 to the plasma membrane and translocation of Daam1 to actin-based stress fibers. Inactivation of Vangl2 had major effects on the podocyte cell shape. These observations confirm that the PCP pathway is functional in podocytes and can exert a powerful influence on organization of the podocyte cytoskeleton.
Within the developing glomerulus, Vangl2 protein was detected in comma-and S-shaped bodies at stages preceding formation of mature podocyte FPs and SDs. Interestingly, in developing podocytes,Vangl2 protein is localized at the most basal aspect of the cell membrane. This is the site of SD assembly between adjacent podocyte FP. We found that Wnt5A induced rapid redistribution of nephrin away from podocyte cell projections. This clearly implies an interaction between the PCP pathway and the SD protein complex, but the physiologic implications are difficult to predict. In other organisms, Wnt signaling may operate transiently during a very narrow developmental window. For example, the Drosophila PCP pathway signaling occurs for only a few hours during larval development (47) . It is conceivable, therefore, that activation of the podocyte PCP pathway may play a crucial, but transient, role before terminal differentiation of SDs. It would be of considerable interest to know whether similar PCP signaling events are reactivated during the response to glomerular podocyte injury in the mature kidney.
To understand how PCP pathway constituents could be linked to the SD, we examined the interaction between Vangl2 and nephrin. Although we detected no evidence of direct interaction between these molecules by yeast two-hybridization assays, we found that Vangl2 participates in a ternary complex with MAGI-2 and nephrin. Other investigators showed that MAGI-1 and -2 proteins directly bind to nephrin (18, 31) . Interestingly, a third member of the MAGI protein family, MAGI-3, has previously been shown to associate with Frizzled-4 and-7 and bind to Vangl2 (63) . Thus, the PCP pathway may have direct links to the multiprotein SD nexus. We hypothesize that activation of the PCP pathway influences assembly of the SD protein complex before terminal differentiation. Similarly, it is conceivable that during the response to glomerular injury, PCP signals are necessary to reestablish podocyte structure preceding final SD reassembly.
A hallmark of PCP signaling is the asymmetric redistribution of proteins at the proximal and distal aspects of the cell along the epithelial plane. Vangl2 and Dvl2 have been shown to localize to opposite sides of the cell in developing fly wings as well as in hair cells of the murine inner ear (35, 47, 58) . By analogy, PCP signaling is predicted to relocate Vangl2 and Dvl2 to opposite sides of the podocyte. Interestingly, Wrana's group reported that Par6 interacts directly with Dvl2; others showed that the Par3/Par6 complex interacts directly with nephrin (19, 21) . Taken together, these observations form the starting point for a hypothetical model of podocyte development in which the strictly alternating pattern of adjacent FP interdigitation is guided by asymmetric constituents in proximal vs. distal SD complexes. Such a model is proposed in Fig. 7 .
During glomerular development, podocyte precursors in the most proximal segment of the S-shaped body shift to envelope the ingrowing glomerular capillary. Arguably, this process requires organized podocyte movement. Podocyte motility may also be an essential component of the response to injury in mature kidney. For example, a decrease in podocyte motility is associated with the detrimental effect of ␣-actinin-4 mutations (23, 29) . A K256E mutation of ␣-actinin-4 detected in familial FSGS was found to change its binding affinity for actin, causing ␣-actinin-4 mislocalization and interference with normal cell adhesion and motility (34) . We show that Wnt5a stimulates directional podocyte movements in vitro. These observations are consistent with the effects of Wnt5a on cell motility reported by others in vivo and in vitro (17, 38) . Conversely, podocyte motility was reduced following siRNA depletion of Vangl2; this is concordant with the reported loss of directional movements by neuroepithelial cells when PCP pathway is disrupted (56, 57) . Our data contrast with the recent report of effects of Vangl2 on motility of human sarcoma HT-1080 cells (2) , but this may reflect the differences between the phenotype of podocytes (or neuroepithelial cells) and cancer cells.
In summary, we show that a functional PCP pathway regulates actin-based cytoskeleton, cell shape, and motility in podocytes. We also propose a molecular link via MAGI-2 between the core PCP protein, Vangl2, and proteins of the podocyte SD complex. We hypothesize that PCP pathway signaling may serve a crucial role in the primary patterning of podocyte FPs in the renal glomerulus and, conceivably, during the recovery of podocytes after glomerular injury.
